JPS6160802B2 - - Google Patents

Info

Publication number
JPS6160802B2
JPS6160802B2 JP2033081A JP2033081A JPS6160802B2 JP S6160802 B2 JPS6160802 B2 JP S6160802B2 JP 2033081 A JP2033081 A JP 2033081A JP 2033081 A JP2033081 A JP 2033081A JP S6160802 B2 JPS6160802 B2 JP S6160802B2
Authority
JP
Japan
Prior art keywords
alkyl
oxy
effect
cosmetic
fair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP2033081A
Other languages
Japanese (ja)
Other versions
JPS57134409A (en
Inventor
Sumyoshi Nagai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sansho Pharmaceutical Co Ltd
Original Assignee
Sansho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sansho Pharmaceutical Co Ltd filed Critical Sansho Pharmaceutical Co Ltd
Priority to JP2033081A priority Critical patent/JPS57134409A/en
Publication of JPS57134409A publication Critical patent/JPS57134409A/en
Publication of JPS6160802B2 publication Critical patent/JPS6160802B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Description

【発明の詳細な説明】 本発明は2−アルキル−5−オキシ−γ−ピロ
ン化合物を含有せしめた美白効果および日焼防止
効果の大なる色白化粧料に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a skin-whitening cosmetic containing a 2-alkyl-5-oxy-γ-pyrone compound, which has great whitening and sun protection effects.

色白の美しい肌にしたいと願うのは女性の常で
あり、従来より過酸化水素、過酸化亜鉛、過酸化
マグネシウム、過酸化ナトリウム、過ホウ酸亜
鉛、過ホウ酸マグネシウムまたは過ホウ酸ナトリ
ウムなどの過酸化物を配合した化粧料が使用され
ていた。しかしながら前記のごとき過酸化物はき
わめて不安定な物質であるため、保存性あるいは
化粧料への配合性などの点に問題があり、かつそ
の美白効果も充分ではなかつた。近年になつて、
ビタミンC、システイン、コロイド硫黄などを配
合した化粧料が開発され賞用されているが、これ
らとてもなお充分に満足しうるものとはいいがた
い。
It is common for women to want to have fair and beautiful skin, and traditionally, treatments such as hydrogen peroxide, zinc peroxide, magnesium peroxide, sodium peroxide, zinc perborate, magnesium perborate, or sodium perborate have been used. Cosmetics containing peroxide were used. However, since the above-mentioned peroxides are extremely unstable substances, there are problems in terms of storage stability and incorporation into cosmetics, and their whitening effect is not sufficient. In recent years,
Cosmetics containing vitamin C, cysteine, colloidal sulfur, etc. have been developed and are now in use, but they are still far from being fully satisfactory.

しかるに、本発明者は人体に好ましくない副作
用を有せず、かつすぐれた美白効果を奏する配合
剤を見出すべく永年にわたつて研究を重ねてきた
ところ、一般式: (式中、Rは低級アルキル基である)で示され
る2−アルキル−5−オキシ−γ−ピロン化合物
がとりわけすぐれたメラニン生成抑制作用を有
し、絶大なる美白効果および日焼防止効果を奏す
るというまつたく新たな事実を見出し、本発明を
完成するにいたつた。
However, the inventors of the present invention have conducted extensive research over many years in order to find a compound that does not have any undesirable side effects on the human body and has an excellent whitening effect, and has found the general formula: The 2-alkyl-5-oxy-γ-pyrone compound represented by the formula (wherein R is a lower alkyl group) has a particularly excellent melanin production inhibiting effect, and has an outstanding whitening effect and sun protection effect. Having discovered this new fact, we have now completed the present invention.

すなわち本発明は適宜の化粧料基材に2−アル
キル−5−オキシ−γ−ピロン化合物を含有せし
めることを要旨とする色白化粧料であつて、ここ
に化粧料基材としては従来より多用されている
種々の基礎化粧料基材、たとえば各種アルコール
類、動植物脂肪、界面活性剤、ペクチン、カルボ
キシメチルセルロース、アルギン酸塩、さらには
安定剤、色素、香料およびその他の成分を適宜配
合し、要すれば加熱溶融または溶融撹拌したもの
などがすべてそのまま採用可能である。
That is, the present invention is a fair-skinned cosmetic comprising a 2-alkyl-5-oxy-γ-pyrone compound contained in a suitable cosmetic base, and wherein a 2-alkyl-5-oxy-γ-pyrone compound is contained in a suitable cosmetic base. Various basic cosmetic base materials, such as various alcohols, animal and vegetable fats, surfactants, pectin, carboxymethyl cellulose, alginates, as well as stabilizers, pigments, fragrances and other ingredients, are blended as appropriate, and if necessary. Anything that has been heated and melted or melted and stirred can be used as is.

本発明に美白剤として用いられる2−アルキル
−5−オキシ−γ−ピロン化合物は、従来のその
作用効果についてほとんど未知の物質であり、か
かる2−アルキル−5−オキシ−γ−ピロン化合
物が人体皮膚のチロジナーゼの作用を阻害し、メ
ラニン生成を抑制して顕著な美白効果を奏するこ
とは従来何人も予期しえなかつたことであり、本
発明者によとつて初めて明らかにされたものであ
る。
The 2-alkyl-5-oxy-γ-pyrone compound used as a skin whitening agent in the present invention is a substance whose action and effect are almost unknown. The fact that it inhibits the action of tyrosinase in the skin and inhibits melanin production, resulting in a remarkable whitening effect, was something that no one could have predicted before, and was revealed for the first time by the present inventor. .

好適に採用される2−アルキル−5−オキシ−
γ−ピロン化合物としては、たとえばアロマルト
ールなどが代表例としてあげられる。これらのγ
−ピロン化合物のメラニン生成抑制作用につい
て、つぎに実験例をあげて説明する。
2-alkyl-5-oxy- preferably employed
A representative example of the γ-pyrone compound is allomaltol. These γ
- The melanin production inhibiting effect of pyrone compounds will be explained below with reference to experimental examples.

実験例 0.01%(重量%、以下同様)マロマルトール水
溶液を調製した。
Experimental Example A 0.01% (wt%) malomaltol aqueous solution was prepared.

ついで、試験管にL−チロジン溶液(0.3mg/
ml)を1ml、マツクルベイン氏の緩衝液(PH
6.8)を1mlおよび前記アロマトール水溶液を0.9
ml入れて37℃の恒温水槽中で10分間インキユベー
トしたのち、これにチロジナーゼ溶液(1mg/
ml)を0.1ml加えてよく撹拌し、ただちに分光光
度計にセツトして475mμにおける吸光度を経時
的(分単位)に測定し、生成してくる赤色のドー
パクローム(メラニン色素の前駆物質)の生成量
と時間との関係を求めた。
Next, add L-tyrosine solution (0.3 mg/
ml) and 1 ml of Matsukulbane's buffer solution (PH
6.8) and 0.9 mL of the above aromatol aqueous solution.
After incubating for 10 minutes in a thermostatic water bath at 37°C, add tyrosinase solution (1 mg/ml) to this.
ml), stir well, and immediately set it in a spectrophotometer to measure the absorbance at 475 mμ over time (in minutes) to determine the formation of red dopachrome (precursor of melanin pigment). We sought the relationship between quantity and time.

添付図面は以上の実験結果を示すグラフである
が、このグラフからアロマルトールがメラニン色
素の前駆物質であるドーパクロームの生成を強力
に抑制する作用を有しており、したがつてすぐれ
た美白効果、日焼防止効果を奏するものであるこ
とがわかる。
The attached drawing is a graph showing the above experimental results, and this graph shows that allomaltol has the effect of strongly suppressing the production of dopachrome, which is a precursor of melanin pigment, and is therefore an excellent whitening agent. It can be seen that it has a sunburn prevention effect.

かかる3(または5)−オキシ−γ−ピロン化
合物は、前記実験結果からわかるように通常0.01
%水溶液ですぐれたドーパクローム生成抑制効果
を発揮するものであり、化粧料基材に2−アルキ
ル−5−オキシ−γ−ピロン化合物を含有せしめ
て本発明の色白化粧料をうるばあい、その含有量
は5%以下、なかんずく0.01〜2.0%程度で充分
であり、このように微量であつても本発明の目的
を完全に達成することができる。
As can be seen from the above experimental results, such 3 (or 5)-oxy-γ-pyrone compounds usually have a concentration of 0.01
% aqueous solution exhibits an excellent effect of inhibiting dopachrome formation, and when the fairing cosmetic of the present invention is prepared by incorporating a 2-alkyl-5-oxy-γ-pyrone compound into a cosmetic base material, A content of 5% or less, especially about 0.01 to 2.0%, is sufficient, and even with such a small amount, the purpose of the present invention can be completely achieved.

またかかる2−アルキル−5−γ−ピロン化合
物は一般に化粧料基材に対する配合性が良好であ
り、かつPH、熱、脱色などに対する経時変化が小
さく安定性が良好であるから、これを含有せしめ
た本発明の色白化粧料は保管中に効能が低下した
り、変質したりすることのない優秀な製品であ
る。
In addition, such 2-alkyl-5-γ-pyrone compounds generally have good blendability in cosmetic base materials, and have good stability with little change over time against pH, heat, decolorization, etc., so they may be included. The fair skin cosmetic of the present invention is an excellent product that does not deteriorate in efficacy or change in quality during storage.

つぎに本発明の色白化粧料の処方例を列挙する
が、本発明はもとよりこれらの処方例のみに限定
されるものではない。
Next, formulation examples of the fair skin cosmetic of the present invention will be listed, but the present invention is not limited to these formulation examples.

処方例 1〔ローシヨン〕 (成 分) (重量部) アロマルトール 0.5 アミノ酢酸 0.20 塩酸ピリドキシン 0.05 フエノールスルホン酸亜鉛 0.30 プロピレングリコール 8.00 エタノール 5.00 精 製 水 86.35 香料および防腐剤 少 量 処方例 2〔パツク〕 (成 分) (重量部) ピロメコン酸 0.25 アミノ酢酸 0.20 フエノールスルホン酸亜鉛 0.30 プロピレングリコール 13.00 カルボキシビニルポリマー 1.20 水酸化ナトリウム 0.14 エタノール 2.50 酸化チタン 0.02 精 製 水 82.54 香料および防腐剤 少 量 処方例 3〔パツク〕 (成 分) (重量部) ポリビニルアルコール 15.00 ポリビニルピロリドン 4.00 プロピレングリコール 6.00 エタノール 10.00 アロマルトール 0.5 精 製 水 69.70 香料および防腐剤 少 量 処方例 4〔ミルクローシヨン〕 (成 分) (重量部) ステアリン酸 2.00 セタノール 0.50 ラノリン 2.00 オレイルオレエート 2.00 スクワラン 3.00 流動パラフイン 8.00 乳 化 剤 2.60 ピロメコン酸 0.2 トリエタノールアミン 1.00 プロピレングリコール 4.00 精 製 水 74.90 香料、酸化防止剤および防腐剤 少 量 処方例 5〔バニシングクリーム〕 (成 分) (重量部) MCステアリン酸 8.00 ミツロウ 5.00 セタノール 3.00 ラノリン 2.00 ミリスチン酸イソプロピル 6.00 流動パラフイン 7.00 オリーブ油 2.00 乳 化 剤 5.50 ピロメコン酸 0.4 トリエタノールアミン 0.60 プロピレングリコール 3.00 精 製 水 57.70 香料、酸化防止剤および防腐剤 少 量 処方例 6〔コールドクリーム〕 (成 分) (重量部) ミツロウ 10.00 セレシン 7.00 白色ワセリン 3.00 ラノリン 3.00 ミリスチン酸イソプロピル 3.00 スクワラン 4.00 流動パラフイン 40.00 ポリオキシエチレンセチルエーテル 2.70 乳 化 剤 2.30 アロマルトール 0.3 プロピレングリコール 2.00 精 製 水 23.00 香料、酸化防止剤および防腐剤 少 量 (メラニン生成抑制試験) 処方例5のクリームを用いて20〜50才の女性65
人の色素沈着症患者に対して3カ月間にわたつて
1日1回患部に塗布した。
Prescription example 1 [Lotion] (Ingredients) (Parts by weight) Allomaltol 0.5 Aminoacetic acid 0.20 Pyridoxine hydrochloride 0.05 Zinc phenolsulfonate 0.30 Propylene glycol 8.00 Ethanol 5.00 Refined water 86.35 Fragrances and preservatives Small amount prescription example 2 [Pack] (Ingredients) (Parts by weight) Pyromeconic acid 0.25 Aminoacetic acid 0.20 Zinc phenolsulfonate 0.30 Propylene glycol 13.00 Carboxyvinyl polymer 1.20 Sodium hydroxide 0.14 Ethanol 2.50 Titanium oxide 0.02 Purified water 82.54 Flavoring and preservative Small amount formulation example 3 [Package] ] (Ingredients) (Parts by weight) Polyvinyl alcohol 15.00 Polyvinylpyrrolidone 4.00 Propylene glycol 6.00 Ethanol 10.00 Aromaltol 0.5 Purified water 69.70 Fragrances and preservatives Small amount formulation example 4 [Milk lotion] (Ingredients) (Parts by weight) Stearic acid 2.00 Setanol 0.50 Lanolin 2.00 Oleyl oleate 2.00 Squalane 3.00 Liquid paraffin 8.00 Emulsifier 2.60 Pyromeconic acid 0.2 Triethanolamine 1.00 Propylene glycol 4.00 Purified water 74.90 Fragrances, antioxidants and preservatives Small quantity formulation example 5 [Vanishing Cream ] (Ingredients) (Parts by weight) MC stearic acid 8.00 Beeswax 5.00 Setanol 3.00 Lanolin 2.00 Isopropyl myristate 6.00 Liquid paraffin 7.00 Olive oil 2.00 Emulsifier 5.50 Pyromeconic acid 0.4 Triethanolamine 0.60 Propylene glycol 3.00 Purified water 57 .70 Fragrances, Antioxidants Semed and preservatives small quantity prescription Example 6 [cold cream] (component) (weight part) white vassin 7.00 white vassin 3.00 ranoline 3.00 msopropyl 3.00 squaralan 4.00 paling paraphroses polyoxyethylene ether 2.370 Emps 2.3. 0 Aroma Lutol 0.3 Propylene glycol 2.00 Purified water 23.00 Fragrances, antioxidants and preservatives Small amounts (Melanin production inhibition test) Women aged 20-50 using the cream of Formulation Example 5 65
It was applied once a day to the affected areas of human patients with hyperpigmentation for three months.

その結果、被検患者のうち症状が完治したもの
21名、症状の改善をみたもの32名、および変化の
なかつたもの12名であつた。
As a result, among the patients tested, the symptoms were completely cured.
21 patients showed improvement in symptoms, 32 patients showed improvement in symptoms, and 12 patients showed no change.

この試験結果から、何らかの症状の改善をみた
ものは81%にも達し、顕著なメラニン生成抑制効
果があることが判明した。
The results of this test showed that as many as 81% of patients saw some improvement in symptoms, indicating that the drug had a significant melanin production suppressing effect.

また処方例6のコールドクリームについても同
様の試験を行なつたところ、同程度の結果がえら
れた。
Further, when a similar test was conducted on the cold cream of Formulation Example 6, similar results were obtained.

【図面の簡単な説明】[Brief explanation of the drawing]

図面はアロマルトールのメラニン生成抑制効果
を示すための、ドーパクロームの生成量と時間と
の関係を示すグラフである。
The figure is a graph showing the relationship between the amount of dopachrome produced and time to show the melanin production inhibiting effect of allomaltol.

Claims (1)

【特許請求の範囲】 1 一般式: (式中、Rは低級アルキル基−である)で示さ
れる2−アルキル−5−オキシ−γ−ピロン化合
物を含有せしめたことを特徴とする色白化粧料。 2 2−アルキル−5−オキシ−γ−ピロン化合
物の含有量が5重量%以下である特許請求の範囲
第1項記載の色白化粧料。 3 2−アルキル−5−オキシ−γ−ピロン化合
物がアロマルトールである特許請求の範囲第1項
または第2項記載の色白化粧料。
[Claims] 1. General formula: A fair-skinned cosmetic containing a 2-alkyl-5-oxy-γ-pyrone compound represented by the formula (wherein R is a lower alkyl group). 2. The fair-skinned cosmetic according to claim 1, wherein the content of the 2-alkyl-5-oxy-γ-pyrone compound is 5% by weight or less. 3. A fair-skinned cosmetic according to claim 1 or 2, wherein the 2-alkyl-5-oxy-γ-pyrone compound is aromaltol.
JP2033081A 1981-02-13 1981-02-13 Whitening cosmetic Granted JPS57134409A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2033081A JPS57134409A (en) 1981-02-13 1981-02-13 Whitening cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2033081A JPS57134409A (en) 1981-02-13 1981-02-13 Whitening cosmetic

Publications (2)

Publication Number Publication Date
JPS57134409A JPS57134409A (en) 1982-08-19
JPS6160802B2 true JPS6160802B2 (en) 1986-12-23

Family

ID=12024122

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2033081A Granted JPS57134409A (en) 1981-02-13 1981-02-13 Whitening cosmetic

Country Status (1)

Country Link
JP (1) JPS57134409A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0655082B2 (en) * 1985-02-27 1994-07-27 株式会社薬理学中央研究所 Method for preventing or recoloring body color of red seafood by .GAMMA.-pyrone derivative
JPH0314508A (en) * 1989-06-12 1991-01-23 Sansho Seiyaku Co Ltd External drug preparation for suppressing melanogenesis
JPH03127712A (en) * 1989-10-09 1991-05-30 Sansho Seiyaku Co Ltd Agent for external application
WO2002053121A1 (en) * 2000-12-30 2002-07-11 Lg Household & Healthcare Co., Ltd. Cosmetic for skin whitening containing acyl substituted derivatives of glucose or sucrose
US20090215887A1 (en) * 2008-02-25 2009-08-27 Eastman Chemical Company 5-hydroxy-2-methyl-4h-pyran-4-one esters as novel tyrosinase inhibitors
US8183398B2 (en) 2008-02-25 2012-05-22 Eastman Chemical Company 5-hydroxy-2-methyl-4H-pyran-4-one esters as novel tyrosinase inhibitors

Also Published As

Publication number Publication date
JPS57134409A (en) 1982-08-19

Similar Documents

Publication Publication Date Title
US5153230A (en) Topical skin cream composition
CA1220717A (en) Composition containing benzoyl peroxide and at least one sun-screen for the treatment of acne
JPS61155302A (en) Skin color-lightening cosmetic
TW477706B (en) Skin tanning compositions and method
US4285967A (en) Cosmetic preparation for reducing redness of blemishes
FR2577805A1 (en) SKIN TREATMENT COMPOSITION BASED ON HYDROQUINONE GLUCOSIDE
CA1171265A (en) Sodium lactate, glycerine, urea and native collagen based wetting composition
JPH0552806B2 (en)
CA1341273C (en) Antioxidant system based on stabilized ascorbyl ester and compositions containing the same
FR2743813A1 (en) STABLE GELIFIED COMPOSITION WITH HIGH ELECTROLYTE CONTENT
JP3135943B2 (en) Whitening agent
JPH0725742A (en) Fair-skinning cosmetic
JPS63192705A (en) External agent for skin
JPS6160802B2 (en)
JPS6245527A (en) Preventive and remedy for gray hair
US5993835A (en) Skin-whitening agent
JPS5811922B2 (en) Keshiyouriyo
US4362747A (en) Cosmetic cream pack formulation
JP2799603B2 (en) Whitening cosmetics
FR2816852A1 (en) Combination of colorant and emulsifier capable of forming stable lamellar emulsion, giving enhanced colorant stability in cosmetic or dermatological compositions
JPH0853327A (en) Hair tonic composed of allantoin or its derivative
JPS6270309A (en) Skin beautifying cosmetic
JP2696523B2 (en) Anti-dandruff agent and hair cosmetic
JP3055826B2 (en) Skin cosmetics
JPS58131911A (en) Cosmetic for fair-complexioned face containing fatty acid ester of quercetin